CJC-1295 DAC

CJC-1295 DAC is a synthetic peptide widely utilized in laboratory research for the study of growth hormone-releasing hormone (GHRH) pathways, receptor binding dynamics, and extended-duration signaling mechanisms. It is commonly investigated for its interaction with GHRH receptors and its ability to sustain receptor activation over prolonged periods, allowing researchers to analyze continuous signaling patterns and downstream cellular responses in controlled experimental models.

In research environments, CJC-1295 DAC is used to explore mechanisms related to endocrine system regulation, protein signaling cascades, and cellular adaptation processes. The Drug Affinity Complex (DAC) component is specifically studied for its role in extending peptide stability and binding duration, making it valuable for examining long-term receptor engagement and hormonal signaling efficiency. This allows for structured investigation into sustained pathway activation, metabolic signaling, and gene expression responses across repeated laboratory protocols.

Reconstitution (For Research Reference Only):
Add 2mL of bacteriostatic water to achieve a concentration of 10mg/mL. At this concentration, each 0.1mL (10 units on a standard insulin syringe) corresponds to 1mg of compound. This information is provided strictly for laboratory research standardization and measurement purposes.

This product is supplied in lyophilized (freeze-dried) form within a sealed vial to ensure stability and precision in handling. It is intended exclusively for laboratory research, analytical, and educational purposes and is not approved for—and must not be used for—human or animal consumption.